Prestige Consumer Healthcare (PBH) Other Non-Current Assets (2011 - 2026)
Prestige Consumer Healthcare (PBH) posted quarterly Other Non-Current Assets of $3.8 million for Q4 2025, down 40.16% year-over-year from $6.3 million in Q4 2024, and up 10.2% quarter-over-quarter from $3.4 million in Q3 2025.
Prestige Consumer Healthcare (PBH) Other Non-Current Assets (2011 - 2026) Analysis & Trends
Prestige Consumer Healthcare's Other Non-Current Assets history runs 15 years deep, the most recent figure standing at $3.8 million for Q4 2025.
- In Q4 2025, Other Non-Current Assets fell 40.16% year-over-year to $3.8 million; the TTM figure through Dec 2025 stood at $3.8 million (down 40.16% YoY), while the FY2025 annual figure was $3.3 million, down 42.83% from the prior year.
- Other Non-Current Assets for Q4 2025 stood at $3.8 million, up from $3.4 million in the prior quarter.
- The five-year high for Other Non-Current Assets was $6.7 million in Q3 2024, with the low at $2.5 million in Q2 2021.
- The 5-year median for Other Non-Current Assets is $3.3 million (2022), against an average of $3.9 million.
- The sharpest annual moves came in 2023 and 2025: Other Non-Current Assets jumped 99.84% in 2023, then tumbled 51.48% in 2025.
- Prestige Consumer Healthcare's Other Non-Current Assets stood at $2.9 million in 2021, then grew by 9.13% to $3.2 million in 2022, then surged by 99.84% to $6.3 million in 2023, then climbed by 0.57% to $6.3 million in 2024, then sank by 40.16% to $3.8 million in 2025.
- Business Quant data shows PBH's Other Non-Current Assets at $3.8 million in Q4 2025, $3.4 million in Q3 2025, and $3.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | 56.35 Mn |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 1.79 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 384.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 503.80 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 239.50 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.06 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 59.30 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 304.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 13.00 Mn |
| 10 | Prestige Consumer Healthcare | 2.44 Bn | 2.37 Bn | - | 10.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.87 Mn |
| Dec 31, 2025 | 3.79 Mn |
| Sep 30, 2025 | 3.44 Mn |
| Jun 30, 2025 | 3.02 Mn |
| Mar 31, 2025 | 3.27 Mn |
| Dec 31, 2024 | 6.34 Mn |
| Sep 30, 2024 | 6.73 Mn |
| Jun 30, 2024 | 6.23 Mn |
| Mar 31, 2024 | 5.73 Mn |
| Dec 31, 2023 | 6.30 Mn |
| Sep 30, 2023 | 3.86 Mn |
| Jun 30, 2023 | 3.27 Mn |
| Mar 31, 2023 | 3.01 Mn |
| Dec 31, 2022 | 3.15 Mn |
| Sep 30, 2022 | 2.58 Mn |
| Jun 30, 2022 | 2.74 Mn |
| Mar 31, 2022 | 3.27 Mn |
| Dec 31, 2021 | 2.89 Mn |
| Sep 30, 2021 | 2.56 Mn |
| Jun 30, 2021 | 2.52 Mn |